NeuBase Therapeutics, Inc. announced on May 12, 2023, Eric J. Ende, M.D. notified the company of his resignation from the board of directors (the board) of the company, effective May 12, 2023. Dr. Ende served as a member of the nominating and corporate governance committee of the board and the compensation committee of the board the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.378 USD | -3.20% | -.--% | -48.93% |
1st Jan change | Capi. | |
---|---|---|
-48.93% | 1.39M | |
+38.90% | 39.1B | |
-7.68% | 38.76B | |
+30.05% | 31.24B | |
+11.10% | 25.9B | |
-13.75% | 25.8B | |
+45.53% | 14.06B | |
+41.83% | 13.12B | |
-6.12% | 11.32B | |
-12.64% | 10.68B |
- Stock Market
- Equities
- O7P Stock
- NBSE Stock
- News NeuBase Therapeutics, Inc.
- NeuBase Therapeutics, Inc. Announces Resignation of Eric J. Ende as Board of Director